Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Depression and Anxiety|January 1, 2019
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depressionNaji C Salloum, Maurizio Fava, Marlene P Freeman, et al.
The Journal of Clinical Psychiatry|November 16, 2022
Effect of Concomitant Benzodiazepines on the Antidepressant Effects of Ketamine: Findings From the RAPID Intravenous Ketamine StudyAnna Feeney, Bettina B Hoeppner, Marlene P Freeman, et al.
Journal of Affective Disorders|February 25, 2020
A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorderTa-Wei Guu, David Mischoulon, Jerome Sarris, et al.
Biological Psychiatry|July 4, 2006
Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorderPaul E Keck, Jim Mintz, Susan L McElroy, et al.
Brain Stimulation|October 15, 2017
Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD)Maurizio Fava, Marlene P Freeman, Martina Flynn, et al.
Contemporary Clinical Trials|March 7, 2013
Design and methods of a multi-site, multi-behavioral treatment trial for menopausal symptoms: the MsFLASH experienceBarbara Sternfeld, Andrea LaCroix, Bette J Caan, et al.
The Lancet. Psychiatry|September 12, 2015
Nutritional medicine as mainstream in psychiatryJerome Sarris, Alan C Logan, Tasnime N Akbaraly, et al.
Molecular Psychiatry|October 5, 2018
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)Maurizio Fava, Marlene P Freeman, Martina Flynn, et al.
Molecular Psychiatry|January 9, 2019
Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)Maurizio Fava, Marlene P Freeman, Martina Flynn, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 21, 2022
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) TaskforceJerome Sarris, Arun Ravindran, Lakshmi N Yatham, et al.
Pageof 14